featured
Trial of the M72/AS01E Vaccine to Prevent Tuberculosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis
N. Engl. J. Med 2018 Oct 25;379(17)1621-1634, O Van Der Meeren, M Hatherill, V Nduba, RJ Wilkinson, M Muyoyeta, E Van Brakel, HM Ayles, G Henostroza, F Thienemann, TJ Scriba, A Diacon, GL Blatner, MA Demoitié, M Tameris, M Malahleha, JC Innes, E Hellström, N Martinson, T Singh, EJ Akite, A Khatoon Azam, A Bollaerts, AM Ginsberg, TG Evans, P Gillard, DR TaitFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.